Rybrevant Faspro (AMIVANTAMAB and HYALURONIDASE-lpuj (HUMAN RECOMBINANT))

**Product type:** Human Prescription Drug

**Active ingredient:** AMIVANTAMAB; HYALURONIDASE (HUMAN RECOMBINANT)

**Strength:** 3520; 44000 mg/22mL; mg/22mL

**Dosage form:** Injection

**Route:** Subcutaneous

**Labeler:** Janssen Biotech, Inc.

**Marketing category:** BLA (BLA761484)

**Pharmacologic class:** Endoglycosidase [EPC], Glycoside Hydrolases [CS]